Hand eczema is a highly prevalent skin disease and one of the most common work-related disorders. In up to two-thirds of individuals affected by hand eczema, the disease becomes chronic and results in ...
Previous studies suggest that patients older than 60 who develop chronic, unexplained eczema are taking more drugs than patients of the same age without eczema and that elderly patients with ...
Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.
Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...
You will be able to get a quick price and instant permission to reuse the content in many different ways. Atopic dermatitis, also known as atopic eczema, is the most common chronic inflammatory skin ...